Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

The evolution of RNA structural probing methods: From gels to next-generation sequencing.

Mailler E, Paillart JC, Marquet R, Smyth RP, Vivet-Boudou V.

Wiley Interdiscip Rev RNA. 2019 Mar;10(2):e1518. doi: 10.1002/wrna.1518. Epub 2018 Nov 28. Review.

PMID:
30485688
2.

The C-terminal p6 domain of the HIV-1 Pr55Gag precursor is required for specific binding to the genomic RNA.

Dubois N, Khoo KK, Ghossein S, Seissler T, Wolff P, McKinstry WJ, Mak J, Paillart JC, Marquet R, Bernacchi S.

RNA Biol. 2018;15(7):923-936. doi: 10.1080/15476286.2018.1481696. Epub 2018 Aug 4.

3.

Preventing tobacco in vocational high schools: study protocol for a randomized controlled trial of P2P, a peer to peer and theory planned behavior-based program.

Cousson-Gélie F, Lareyre O, Margueritte M, Paillart J, Huteau ME, Djoufelkit K, Pereira B, Stoebner A.

BMC Public Health. 2018 Apr 13;18(1):494. doi: 10.1186/s12889-018-5226-y.

4.

Structural and Functional Motifs in Influenza Virus RNAs.

Ferhadian D, Contrant M, Printz-Schweigert A, Smyth RP, Paillart JC, Marquet R.

Front Microbiol. 2018 Mar 29;9:559. doi: 10.3389/fmicb.2018.00559. eCollection 2018. Review.

5.

Retroviral RNA Dimerization: From Structure to Functions.

Dubois N, Marquet R, Paillart JC, Bernacchi S.

Front Microbiol. 2018 Mar 22;9:527. doi: 10.3389/fmicb.2018.00527. eCollection 2018. Review.

6.

In cell mutational interference mapping experiment (in cell MIME) identifies the 5' polyadenylation signal as a dual regulator of HIV-1 genomic RNA production and packaging.

Smyth RP, Smith MR, Jousset AC, Despons L, Laumond G, Decoville T, Cattenoz P, Moog C, Jossinet F, Mougel M, Paillart JC, von Kleist M, Marquet R.

Nucleic Acids Res. 2018 May 18;46(9):e57. doi: 10.1093/nar/gky152.

7.

Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.

Seissler T, Marquet R, Paillart JC.

Viruses. 2017 Oct 31;9(11). pii: E322. doi: 10.3390/v9110322. Review.

8.

Molecular architecture and dynamics of ASH1 mRNA recognition by its mRNA-transport complex.

Edelmann FT, Schlundt A, Heym RG, Jenner A, Niedner-Boblenz A, Syed MI, Paillart JC, Stehle R, Janowski R, Sattler M, Jansen RP, Niessing D.

Nat Struct Mol Biol. 2017 Feb;24(2):152-161. doi: 10.1038/nsmb.3351. Epub 2017 Jan 16.

PMID:
28092367
9.

Argonaute proteins regulate HIV-1 multiply spliced RNA and viral production in a Dicer independent manner.

Eckenfelder A, Ségéral E, Pinzón N, Ulveling D, Amadori C, Charpentier M, Nidelet S, Concordet JP, Zagury JF, Paillart JC, Berlioz-Torrent C, Seitz H, Emiliani S, Gallois-Montbrun S.

Nucleic Acids Res. 2017 Apr 20;45(7):4158-4173. doi: 10.1093/nar/gkw1289.

10.

Translational regulation of APOBEC3G mRNA by Vif requires its 5'UTR and contributes to restoring HIV-1 infectivity.

Guerrero S, Libre C, Batisse J, Mercenne G, Richer D, Laumond G, Decoville T, Moog C, Marquet R, Paillart JC.

Sci Rep. 2016 Dec 20;6:39507. doi: 10.1038/srep39507.

11.

HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Bernacchi S, Abd El-Wahab EW, Dubois N, Hijnen M, Smyth RP, Mak J, Marquet R, Paillart JC.

RNA Biol. 2017 Jan 2;14(1):90-103. doi: 10.1080/15476286.2016.1256533. Epub 2016 Nov 14.

12.

The Life-Cycle of the HIV-1 Gag-RNA Complex.

Mailler E, Bernacchi S, Marquet R, Paillart JC, Vivet-Boudou V, Smyth RP.

Viruses. 2016 Sep 10;8(9). pii: E248. doi: 10.3390/v8090248. Review.

13.

Characterization of the interaction between the HIV-1 Gag structural polyprotein and the cellular ribosomal protein L7 and its implication in viral nucleic acid remodeling.

Mekdad HE, Boutant E, Karnib H, Biedma ME, Sharma KK, Malytska I, Laumond G, Roy M, Réal E, Paillart JC, Moog C, Darlix JL, Mély Y, de Rocquigny H.

Retrovirology. 2016 Aug 11;13(1):54. doi: 10.1186/s12977-016-0287-4.

14.

Requirements for nucleocapsid-mediated regulation of reverse transcription during the late steps of HIV-1 assembly.

Racine PJ, Chamontin C, de Rocquigny H, Bernacchi S, Paillart JC, Mougel M.

Sci Rep. 2016 Jun 7;6:27536. doi: 10.1038/srep27536.

15.

Mutational interference mapping experiment (MIME) for studying RNA structure and function.

Smyth RP, Despons L, Huili G, Bernacchi S, Hijnen M, Mak J, Jossinet F, Weixi L, Paillart JC, von Kleist M, Marquet R.

Nat Methods. 2015 Sep;12(9):866-72. doi: 10.1038/nmeth.3490. Epub 2015 Aug 3.

PMID:
26237229
16.

The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.

Valera MS, de Armas-Rillo L, Barroso-González J, Ziglio S, Batisse J, Dubois N, Marrero-Hernández S, Borel S, García-Expósito L, Biard-Piechaczyk M, Paillart JC, Valenzuela-Fernández A.

Retrovirology. 2015 Jun 24;12:53. doi: 10.1186/s12977-015-0181-5.

17.

HIV-1 replication and the cellular eukaryotic translation apparatus.

Guerrero S, Batisse J, Libre C, Bernacchi S, Marquet R, Paillart JC.

Viruses. 2015 Jan 19;7(1):199-218. doi: 10.3390/v7010199. Review.

18.

HIV-1 viral infectivity factor interacts with microtubule-associated protein light chain 3 and inhibits autophagy.

Borel S, Robert-Hebmann V, Alfaisal J, Jain A, Faure M, Espert L, Chaloin L, Paillart JC, Johansen T, Biard-Piechaczyk M.

AIDS. 2015 Jan 28;29(3):275-86.

PMID:
25490467
19.

Evaluation of anti-HIV-1 mutagenic nucleoside analogues.

Vivet-Boudou V, Isel C, El Safadi Y, Smyth RP, Laumond G, Moog C, Paillart JC, Marquet R.

J Biol Chem. 2015 Jan 2;290(1):371-83. doi: 10.1074/jbc.M114.616383. Epub 2014 Nov 14.

20.

Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.

Sleiman D, Bernacchi S, Xavier Guerrero S, Brachet F, Larue V, Paillart JC, Tisne C.

RNA Biol. 2014;11(7):906-20. doi: 10.4161/rna.29546. Epub 2014 Jul 22.

21.

Specific recognition of the HIV-1 genomic RNA by the Gag precursor.

Abd El-Wahab EW, Smyth RP, Mailler E, Bernacchi S, Vivet-Boudou V, Hijnen M, Jossinet F, Mak J, Paillart JC, Marquet R.

Nat Commun. 2014 Jul 2;5:4304. doi: 10.1038/ncomms5304.

PMID:
24986025
22.

CTIP2 is a negative regulator of P-TEFb.

Cherrier T, Le Douce V, Eilebrecht S, Riclet R, Marban C, Dequiedt F, Goumon Y, Paillart JC, Mericskay M, Parlakian A, Bausero P, Abbas W, Herbein G, Kurdistani SK, Grana X, Van Driessche B, Schwartz C, Candolfi E, Benecke AG, Van Lint C, Rohr O.

Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12655-60. doi: 10.1073/pnas.1220136110. Epub 2013 Jul 12.

23.

APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.

Batisse J, Guerrero SX, Bernacchi S, Richert L, Godet J, Goldschmidt V, Mély Y, Marquet R, de Rocquigny H, Paillart JC.

J Virol. 2013 Jun;87(11):6492-506. doi: 10.1128/JVI.03494-12. Epub 2013 Apr 10.

24.

Interaction network linking the human H3N2 influenza A virus genomic RNA segments.

Fournier E, Moules V, Essere B, Paillart JC, Sirbat JD, Cavalier A, Rolland JP, Thomas D, Lina B, Isel C, Marquet R.

Vaccine. 2012 Dec 7;30(51):7359-67. doi: 10.1016/j.vaccine.2012.09.079. Epub 2012 Oct 9.

PMID:
23063835
25.

The role of Vif oligomerization and RNA chaperone activity in HIV-1 replication.

Batisse J, Guerrero S, Bernacchi S, Sleiman D, Gabus C, Darlix JL, Marquet R, Tisné C, Paillart JC.

Virus Res. 2012 Nov;169(2):361-76. doi: 10.1016/j.virusres.2012.06.018. Epub 2012 Jun 21. Review.

PMID:
22728817
26.

Initiation of HIV-1 reverse transcription and functional role of nucleocapsid-mediated tRNA/viral genome interactions.

Sleiman D, Goldschmidt V, Barraud P, Marquet R, Paillart JC, Tisné C.

Virus Res. 2012 Nov;169(2):324-39. doi: 10.1016/j.virusres.2012.06.006. Epub 2012 Jun 18. Review.

PMID:
22721779
27.

[A transcription factor acts as a HIV-1 accomplice to destroy the cellular defences].

Marquet R, Guerrero S, Bernacchi S, Pernot S, Batisse J, Paillart JC.

Med Sci (Paris). 2012 Apr;28(4):356-8. doi: 10.1051/medsci/2012284007. Epub 2012 Apr 25. French. No abstract available.

28.

A supramolecular assembly formed by influenza A virus genomic RNA segments.

Fournier E, Moules V, Essere B, Paillart JC, Sirbat JD, Isel C, Cavalier A, Rolland JP, Thomas D, Lina B, Marquet R.

Nucleic Acids Res. 2012 Mar;40(5):2197-209. doi: 10.1093/nar/gkr985. Epub 2011 Nov 10.

29.

Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif.

Bernacchi S, Mercenne G, Tournaire C, Marquet R, Paillart JC.

Nucleic Acids Res. 2011 Mar;39(6):2404-15. doi: 10.1093/nar/gkq979. Epub 2010 Nov 13.

30.

5-Modified-2'-dU and 2'-dC as mutagenic anti HIV-1 proliferation agents: synthesis and activity.

El Safadi Y, Paillart JC, Laumond G, Aubertin AM, Burger A, Marquet R, Vivet-Boudou V.

J Med Chem. 2010 Feb 25;53(4):1534-45. doi: 10.1021/jm901758f.

PMID:
20112915
31.

HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation.

Mercenne G, Bernacchi S, Richer D, Bec G, Henriet S, Paillart JC, Marquet R.

Nucleic Acids Res. 2010 Jan;38(2):633-46. doi: 10.1093/nar/gkp1009. Epub 2009 Nov 12.

32.

Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.

Henriet S, Mercenne G, Bernacchi S, Paillart JC, Marquet R.

Microbiol Mol Biol Rev. 2009 Jun;73(2):211-32. doi: 10.1128/MMBR.00040-08. Review.

33.

Advances in the structural understanding of Vif proteins.

Barraud P, Paillart JC, Marquet R, Tisné C.

Curr HIV Res. 2008 Mar;6(2):91-9. Review.

34.
35.

In vitro dimerization of human immunodeficiency virus type 1 (HIV-1) spliced RNAs.

Sinck L, Richer D, Howard J, Alexander M, Purcell DF, Marquet R, Paillart JC.

RNA. 2007 Dec;13(12):2141-50. Epub 2007 Oct 9.

36.

Synthesis of a neamine dimer targeting the dimerization initiation site of HIV-1 RNA.

Bodlenner A, Alix A, Weibel JM, Pale P, Ennifar E, Paillart JC, Walter P, Marquet R, Dumas P.

Org Lett. 2007 Oct 25;9(22):4415-8. Epub 2007 Oct 4.

PMID:
17915882
37.

Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription.

Henriet S, Sinck L, Bec G, Gorelick RJ, Marquet R, Paillart JC.

Nucleic Acids Res. 2007;35(15):5141-53. Epub 2007 Jul 26.

38.

RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.

Bernacchi S, Henriet S, Dumas P, Paillart JC, Marquet R.

J Biol Chem. 2007 Sep 7;282(36):26361-8. Epub 2007 Jul 2.

39.

A structure-based approach for targeting the HIV-1 genomic RNA dimerization initiation site.

Ennifar E, Paillart JC, Bernacchi S, Walter P, Pale P, Decout JL, Marquet R, Dumas P.

Biochimie. 2007 Oct;89(10):1195-203. Epub 2007 Mar 12. Review.

PMID:
17434658
40.

HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms.

Houzet L, Paillart JC, Smagulova F, Maurel S, Morichaud Z, Marquet R, Mougel M.

Nucleic Acids Res. 2007;35(8):2695-704. Epub 2007 Apr 10.

41.

Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell.

Ennifar E, Paillart JC, Bodlenner A, Walter P, Weibel JM, Aubertin AM, Pale P, Dumas P, Marquet R.

Nucleic Acids Res. 2006 May 5;34(8):2328-39. Print 2006.

42.

Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.

Henriet S, Richer D, Bernacchi S, Decroly E, Vigne R, Ehresmann B, Ehresmann C, Paillart JC, Marquet R.

J Mol Biol. 2005 Nov 18;354(1):55-72. Epub 2005 Oct 3.

PMID:
16236319
43.

First snapshots of the HIV-1 RNA structure in infected cells and in virions.

Paillart JC, Dettenhofer M, Yu XF, Ehresmann C, Ehresmann B, Marquet R.

J Biol Chem. 2004 Nov 12;279(46):48397-403. Epub 2004 Sep 8.

44.

Structural variability of the initiation complex of HIV-1 reverse transcription.

Goldschmidt V, Paillart JC, Rigourd M, Ehresmann B, Aubertin AM, Ehresmann C, Marquet R.

J Biol Chem. 2004 Aug 20;279(34):35923-31. Epub 2004 Jun 11.

45.

Dimerization of retroviral RNA genomes: an inseparable pair.

Paillart JC, Shehu-Xhilaga M, Marquet R, Mak J.

Nat Rev Microbiol. 2004 Jun;2(6):461-72. Review. No abstract available.

PMID:
15152202
46.

HIV-1 RNA dimerization initiation site is structurally similar to the ribosomal A site and binds aminoglycoside antibiotics.

Ennifar E, Paillart JC, Marquet R, Ehresmann B, Ehresmann C, Dumas P, Walter P.

J Biol Chem. 2003 Jan 24;278(4):2723-30. Epub 2002 Nov 14.

47.

In vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNA.

Paillart JC, Skripkin E, Ehresmann B, Ehresmann C, Marquet R.

J Biol Chem. 2002 Feb 22;277(8):5995-6004. Epub 2001 Dec 13.

48.

Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium binding.

Jossinet F, Paillart JC, Westhof E, Hermann T, Skripkin E, Lodmell JS, Ehresmann C, Ehresmann B, Marquet R.

RNA. 1999 Sep;5(9):1222-34.

50.

Oligonucleotide-mediated inhibition of genomic RNA dimerization of HIV-1 strains MAL and LAI: a comparative analysis.

Lodmell JS, Paillart JC, Mignot D, Ehresmann B, Ehresmann C, Marquet R.

Antisense Nucleic Acid Drug Dev. 1998 Dec;8(6):517-29.

PMID:
9918116

Supplemental Content

Loading ...
Support Center